PAPER Amiri S, Keffeler JI, Crain DR, Denney JT, Buchwald D
SEARCH RESULTS
18453 RESULTS
PAPER Larsen FK, Baksh RA, McGlinchey E, Langballe EM, Benejam B, Beresford-Webb J, McCarron M, Coppus A, Falquero S, Fortea J, Levin J, Loosli SV, Mark R, Rebillat AS, Zaman S, Strydom A
Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium.
Alzheimers Dement. 2024 May;20(5):3270-3280. Epub 2024 Mar 20 PubMed.PAPER Zhang Z, Wang Y, Wang J, Cai Y, Liu P, Liu S, Wu J, Xie X
The role of peripheral inflammation-related biomarkers in distinguishing Parkinson's disease.
Parkinsonism Relat Disord. 2024 Jun;123:106102. Epub 2024 Mar 16 PubMed.PAPER Baytas IM
Predicting Progression From Mild Cognitive Impairment to Alzheimer's Dementia With Adversarial Attacks.
IEEE J Biomed Health Inform. 2024 Jun;28(6):3750-3761. Epub 2024 Jun 6 PubMed.PAPER Laursen AS, Olesen MV, Folke J, Brudek T, Knecht LH, Sotty F, Lambertsen KL, Fog K, Dalgaard LT, Aznar S
Systemic inflammation activates coagulation and immune cell infiltration pathways in brains with propagating α-synuclein fibril aggregates.
Mol Cell Neurosci. 2024 Jun;129:103931. Epub 2024 Mar 19 PubMed.PAPER Nagayama T, Yagishita S, Shibata M, Furuno A, Saito T, Saido TC, Wakatsuki S, Araki T
Transient sleep apnea results in long-lasting increase in β-amyloid generation and tau hyperphosphorylation.
Neurosci Res. 2024 Aug;205:40-46. Epub 2024 Mar 19 PubMed.PAPER Meeker KL, Luckett PH, Barthélemy NR, Hobbs DA, Chen C, Bollinger J, Ovod V, Flores S, Keefe S, Henson RL, Herries EM, McDade E, Hassenstab JJ, Xiong C, Cruchaga C, Benzinger TL, Holtzman DM, Schindler SE, Bateman RJ, Morris JC, Gordon BA, Ances BM
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease.
Brain Commun. 2024;6(2):fcae081. Epub 2024 Mar 15 PubMed.PAPER Geertsma HM, Fisk ZA, Sauline L, Prigent A, Kurgat K, Callaghan SM, aSCENT-PD Consortium, Henderson MX, Rousseaux MW
A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs.
NPJ Parkinsons Dis. 2024 Mar 19;10(1):65. PubMed.PAPER Petersen B, Negri S, Milan M, Shi H, Reyff Z, Ballard C, Ihuoma J, Di Francesco A, Tarantini S
Editorial: Effects of vascular function and aging on brain circulation and neurodegeneration.
Front Aging. 2024;5:1385066. Epub 2024 Mar 5 PubMed.PAPER Yu Z, Luo F
The Role of Reactive Oxygen Species in Alzheimer's Disease: From Mechanism to Biomaterials Therapy.
Adv Healthc Mater. 2024 Mar 20;:e2304373. PubMed.PAPER Sánchez-Soblechero A, Berbel A, Villarejo A, Palmí-Cortés I, Vieira A, Gil-Moreno MJ, Fernández C, Martín-Montes Ã, Carreras MT, Fernández Y, Puertas C, Blanco-Palmero V, Llamas S, González-Sánchez M, Lapeña T, de Luis P, Manzano S, Olazarán J
Translating NIA-AA criteria into usual practice: Report from the ReDeMa Project.
Alzheimers Dement (N Y). 2024;10(1):e12451. Epub 2024 Mar 18 PubMed.PAPER Shi J, Wang Z, Yi M, Xie S, Zhang X, Tao D, Liu Y, Yang Y
Evidence based on Mendelian randomization and colocalization analysis strengthens causal relationships between structural changes in specific brain regions and risk of amyotrophic lateral sclerosis.
Front Neurosci. 2024;18:1333782. Epub 2024 Mar 5 PubMed.PAPER Nimmo J, Byrne RA, Daskoulidou N, Watkins LM, Carpanini SM, Zelek WM, Morgan BP
The complement system in neurodegenerative diseases.
Clin Sci (Lond). 2024 Mar 20;138(6):387-412. PubMed. Correction.PAPER Jackson RJ, Keiser MS, Meltzer JC, Fykstra DP, Dierksmeier SE, Hajizadeh S, Kreuzer J, Morris R, Melloni A, Nakajima T, Tecedor L, Ranum PT, Carrell E, Chen Y, Nishtar MA, Holtzman DM, Haas W, Davidson BL, Hyman BT
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease.
Mol Ther. 2024 May 1;32(5):1373-1386. Epub 2024 Mar 19 PubMed.Liwen Zhang
Current Filters
- Date Range : Mar 2024 to Mar 2025 x